Targeted Therapies and Biomarkers in Small Cell Lung Cancer
Hirokazu Taniguchi(Kanazawa University), Charles M. Rudin(Memorial Sloan Kettering Cancer Center)
Cited by 112
Related Papers
Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449
|New England Journal of Medicine|2009|1k
AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells
|Nature Communications|2019|360
Comprehensive molecular characterization of lung tumors implicates AKT and MYC signaling in adenocarcinoma to squamous cell transdifferentiation
|Journal of Hematology & Oncology|2021|92
Exportin 1 inhibition prevents neuroendocrine transformation through SOX2 down-regulation in lung and prostate cancers
|Science Translational Medicine|2023|44
Targeting NFE2L2/KEAP1 Mutations in Advanced NSCLC With the TORC1/2 Inhibitor TAK-228
|Journal of Thoracic Oncology|2022|35